Provided by Tiger Fintech (Singapore) Pte. Ltd.

VITASORA HEALTH LIMITED

0.036
-0.001-2.70%
Volume:269.81K
Turnover:9.85K
Market Cap:56.77M
PE:-5.55
High:0.037
Open:0.036
Low:0.036
Close:0.037
Loading ...

Company Profile

Company Name:
VITASORA HEALTH LIMITED
Exchange:
ASX
Establishment Date:
1987
Employees:
30
Office Location:
432 St Kilda Road,Suite 1, Level 9,Melbourne,Victoria,Australia
Zip Code:
3004
Fax:
61 3 9822 7735
Introduction:
Respiri Limited, a health technology company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; Wholter, a device for home ambulatory recording of nocturnal wheeze and cough; and AirSonea, a digital stethoscope that is paired to a smartphone app to record breathing sounds accurately. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs; and SonoSentry, an over-the-counter wheeze-detection device. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited was incorporated in 1987 and is based in Melbourne, Australia.